127 related articles for article (PubMed ID: 19556010)
1. Pravastatin prevents miscarriages in antiphospholipid antibody-treated mice.
Girardi G
J Reprod Immunol; 2009 Nov; 82(2):126-31. PubMed ID: 19556010
[TBL] [Abstract][Full Text] [Related]
2. Neutrophil activation by the tissue factor/Factor VIIa/PAR2 axis mediates fetal death in a mouse model of antiphospholipid syndrome.
Redecha P; Franzke CW; Ruf W; Mackman N; Girardi G
J Clin Invest; 2008 Oct; 118(10):3453-61. PubMed ID: 18802482
[TBL] [Abstract][Full Text] [Related]
3. Role of tissue factor in the maternal immunological attack of the embryo in the antiphospholipid syndrome.
Girardi G
Clin Rev Allergy Immunol; 2010 Dec; 39(3):160-5. PubMed ID: 19921475
[TBL] [Abstract][Full Text] [Related]
4. Tissue factor: a link between C5a and neutrophil activation in antiphospholipid antibody induced fetal injury.
Redecha P; Tilley R; Tencati M; Salmon JE; Kirchhofer D; Mackman N; Girardi G
Blood; 2007 Oct; 110(7):2423-31. PubMed ID: 17536017
[TBL] [Abstract][Full Text] [Related]
5. Tissue factor in antiphospholipid antibody-induced pregnancy loss: a pro-inflammatory molecule.
Girardi G; Mackman N
Lupus; 2008 Oct; 17(10):931-6. PubMed ID: 18827058
[TBL] [Abstract][Full Text] [Related]
6. Complement inhibition keeps mothers calm and avoids fetal rejection.
Girardi G
Immunol Invest; 2008; 37(5):645-59. PubMed ID: 18716942
[TBL] [Abstract][Full Text] [Related]
7. Tracing the molecular pathogenesis of antiphospholipid syndrome.
Weiler H
J Clin Invest; 2008 Oct; 118(10):3276-8. PubMed ID: 18802489
[TBL] [Abstract][Full Text] [Related]
8. Role of tissue factor in pregnancy complications: crosstalk between coagulation and inflammation.
Girardi G
Thromb Res; 2011 Feb; 127 Suppl 3():S43-6. PubMed ID: 21262438
[TBL] [Abstract][Full Text] [Related]
9. Guilty as charged: all available evidence implicates complement's role in fetal demise.
Girardi G
Am J Reprod Immunol; 2008 Mar; 59(3):183-92. PubMed ID: 18275511
[TBL] [Abstract][Full Text] [Related]
10. Modulation of tissue factor and tissue factor pathway inhibitor-1 by neutrophil proteases.
Steppich BA; Seitz I; Busch G; Stein A; Ott I
Thromb Haemost; 2008 Dec; 100(6):1068-75. PubMed ID: 19132232
[TBL] [Abstract][Full Text] [Related]
11. Heparin prevents antiphospholipid antibody-induced fetal loss by inhibiting complement activation.
Girardi G; Redecha P; Salmon JE
Nat Med; 2004 Nov; 10(11):1222-6. PubMed ID: 15489858
[TBL] [Abstract][Full Text] [Related]
12. Pravastatin does not prevent antiphospholipid antibody-mediated changes in human first trimester trophoblast function.
Odiari EA; Mulla MJ; Sfakianaki AK; Paidas MJ; Stanwood NL; Gariepy A; Brosens JJ; Chamley LW; Abrahams VM
Hum Reprod; 2012 Oct; 27(10):2933-40. PubMed ID: 22888169
[TBL] [Abstract][Full Text] [Related]
13. Anti-phospholipid antibody mediated fetal loss: still an open question from a pathogenic point of view.
Meroni PL; Tedesco F; Locati M; Vecchi A; Di Simone N; Acaia B; Pierangeli SS; Borghi MO
Lupus; 2010 Apr; 19(4):453-6. PubMed ID: 20353987
[TBL] [Abstract][Full Text] [Related]
14. Requirement of activation of complement C3 and C5 for antiphospholipid antibody-mediated thrombophilia.
Pierangeli SS; Girardi G; Vega-Ostertag M; Liu X; Espinola RG; Salmon J
Arthritis Rheum; 2005 Jul; 52(7):2120-4. PubMed ID: 15986360
[TBL] [Abstract][Full Text] [Related]
15. Intracellular signaling triggered by antiphospholipid antibodies in platelets and endothelial cells: a pathway to targeted therapies.
Pierangeli SS; Vega-Ostertag M; Harris EN
Thromb Res; 2004; 114(5-6):467-76. PubMed ID: 15507280
[TBL] [Abstract][Full Text] [Related]
16. Antiphospholipid antibodies from patients with the antiphospholipid syndrome induce monocyte tissue factor expression through the simultaneous activation of NF-kappaB/Rel proteins via the p38 mitogen-activated protein kinase pathway, and of the MEK-1/ERK pathway.
López-Pedrera C; Buendía P; Cuadrado MJ; Siendones E; Aguirre MA; Barbarroja N; Montiel-Duarte C; Torres A; Khamashta M; Velasco F
Arthritis Rheum; 2006 Jan; 54(1):301-11. PubMed ID: 16385547
[TBL] [Abstract][Full Text] [Related]
17. Impaired expression of endometrial differentiation markers and complement regulatory proteins in patients with recurrent pregnancy loss associated with antiphospholipid syndrome.
Francis J; Rai R; Sebire NJ; El-Gaddal S; Fernandes MS; Jindal P; Lokugamage A; Regan L; Brosens JJ
Mol Hum Reprod; 2006 Jul; 12(7):435-42. PubMed ID: 16735457
[TBL] [Abstract][Full Text] [Related]
18. A novel inhibitor of the alternative complement pathway prevents antiphospholipid antibody-induced pregnancy loss in mice.
Thurman JM; Kraus DM; Girardi G; Hourcade D; Kang HJ; Royer PA; Mitchell LM; Giclas PC; Salmon J; Gilkeson G; Holers VM
Mol Immunol; 2005 Jan; 42(1):87-97. PubMed ID: 15488947
[TBL] [Abstract][Full Text] [Related]
19. Novel considerations in the pathogenesis of the antiphospholipid syndrome: involvement of the tissue factor pathway of blood coagulation.
Adams M
Semin Thromb Hemost; 2008 Apr; 34(3):251-5. PubMed ID: 18720304
[TBL] [Abstract][Full Text] [Related]
20. Antiphospholipid syndrome: definition and treatment.
Galli M; Barbui T
Semin Thromb Hemost; 2003 Apr; 29(2):195-204. PubMed ID: 12709923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
